| Medical and Health Sciences | Lifetime | 935 | GB 100 | 99.96 |
| Mathematics and Statistics | Lifetime | 72 | GB 8 | 99.83 |
| Mathematics and Statistics | 2021-2025 | 466 | GB 22 | 95.64 |
| Statistics, Probability and Uncertainty | Lifetime | 6 | GB 3 | 99.92 |
| Infectious Diseases | Lifetime | 61 | GB 3 | 99.80 |
| General Health Professions | Lifetime | 911 | GB 144 | 98.94 |
| Epidemiology | Lifetime | 968 | GB 88 | 98.70 |
| Emergency Medicine | Lifetime | 511 | GB 43 | 95.27 |
| Virology | Lifetime | 247 | GB 21 | 95.15 |
| Statistics and Probability | Lifetime | 694 | GB 76 | 93.90 |
| Health | Lifetime | 985 | GB 127 | 91.24 |
| Microbiology | Lifetime | 492 | GB 48 | 89.12 |
| Immunology and Allergy | Lifetime | 702 | GB 70 | 85.31 |
| Infectious Diseases | 2021-2025 | 130 | GB 12 | 97.92 |
| Statistics, Probability and Uncertainty | 2021-2025 | 120 | GB 11 | 93.36 |
| Oncology | 2021-2025 | 699 | GB 38 | 89.06 |
| HIV/AIDS Research and Interventions | Lifetime | 18 | GB 2 | 99.89 |
| Meta-analysis and systematic reviews | Lifetime | 6 | GB 3 | 99.88 |
| HIV/AIDS drug development and treatment | Lifetime | 55 | GB 5 | 99.66 |
| Clinical practice guidelines implementation | Lifetime | 30 | GB 4 | 99.42 |
| Delphi Technique in Research | Lifetime | 18 | GB 6 | 99.41 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 154 | GB 25 | 99.48 |
| HIV Research and Treatment | Lifetime | 122 | GB 11 | 99.58 |
| Statistical Methods in Clinical Trials | Lifetime | 42 | GB 11 | 98.98 |
| Reliability and Agreement in Measurement | Lifetime | 5 | GB 2 | 99.00 |
| Health, Environment, Cognitive Aging | Lifetime | 48 | GB 15 | 98.99 |
| HIV-related health complications and treatments | Lifetime | 70 | GB 5 | 99.13 |
| HIV, Drug Use, Sexual Risk | Lifetime | 166 | GB 19 | 98.82 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 229 | GB 22 | 98.60 |
| Health Sciences Research and Education | Lifetime | 90 | GB 13 | 97.88 |
| Viral-associated cancers and disorders | Lifetime | 522 | GB 38 | 97.33 |
| Health and Medical Research Impacts | Lifetime | 294 | GB 35 | 93.99 |
| Adolescent Sexual and Reproductive Health | Lifetime | 839 | GB 75 | 96.45 |
| Health and Medical Studies | Lifetime | 407 | GB 3 | 94.73 |
| Reproductive tract infections research | Lifetime | 788 | GB 85 | 94.87 |
| Food Allergy and Anaphylaxis Research | Lifetime | 902 | GB 62 | 94.56 |
| Health Policy Implementation Science | Lifetime | 970 | GB 155 | 93.18 |
| scientometrics and bibliometrics research | Lifetime | 689 | GB 58 | 85.88 |
| Advanced Causal Inference Techniques | Lifetime | 858 | GB 96 | 84.19 |
| Belt Conveyor Systems Engineering | Lifetime | 893 | GB 26 | 66.13 |
| Academic Writing and Publishing | Lifetime | 496 | GB 67 | 59.35 |
| Academic Publishing and Open Access | Lifetime | 673 | GB 64 | 55.45 |
| HIV/AIDS drug development and treatment | 2021-2025 | 29 | GB 3 | 98.22 |
| HIV/AIDS Research and Interventions | 2021-2025 | 71 | GB 4 | 98.83 |
| HIV Research and Treatment | 2021-2025 | 72 | GB 4 | 97.85 |
| HIV-related health complications and treatments | 2021-2025 | 66 | GB 5 | 96.08 |
| COVID-19 and healthcare impacts | 2021-2025 | 361 | GB 81 | 94.17 |
| Meta-analysis and systematic reviews | 2021-2025 | 135 | GB 23 | 92.83 |
| Viral-associated cancers and disorders | 2021-2025 | 331 | GB 8 | 89.17 |
| Statistical Methods in Clinical Trials | 2021-2025 | 369 | GB 55 | 82.04 |
| HIV/AIDS Impact and Responses | 2021-2025 | 203 | GB 17 | 76.20 |
| Infection Control and Ventilation | 2021-2025 | 875 | GB 71 | 75.12 |
| scientometrics and bibliometrics research | 2021-2025 | 383 | GB 19 | 68.75 |
| Advanced Causal Inference Techniques | 2021-2025 | 581 | GB 61 | 66.79 |